TRAX Exercise Disclosure
Orwin John A · SEC Form 4 · Filed Sep 17, 2026
Exercise
Calculated transaction value
$0
Orwin John A Director
TRAX
Transaction date
Sep 15, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed 2 days later
TRAX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Unit on Common Stock
- Quantity / price
- 1,300 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001477384-26-000012
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| First Tracks Biotherapeutics, Inc. TRAX | Exercise | Sep 15, 2026 | $0 |
| First Tracks Biotherapeutics, Inc. TRAX Current | Exercise | Sep 15, 2026 | $0 |